Article info
Extended report
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis
- Professor T Thomas, INSERM U890, Rheumatology Department, University Hospital, Boulevard Pasteur, 42055 SAINT-ETIENNE Cedex2, France; thierry.thomas{at}univ-st-etienne.fr
Citation
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis
Publication history
- Accepted July 10, 2007
- Final version accepted July 20, 2007
- First published July 20, 2007.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and European League Against Rheumatism